pembrolizumab and epacadostat for nsclc: echo-306/keynote-715
Published 6 years ago • 146 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:22
updated outcomes of keynote-010 of pembrolizumab for nsclc
-
1:50
dr. hamid on epacadostat plus pembrolizumab in advanced melanoma
-
3:26
phase ii trial of pembro & epacadostat in patients with recurrent clear cell carcinoma of the ovary
-
7:16
epacadostat plus pembrolizumab in patients with scchn: preliminary results from echo-202/keynote-037
-
1:09
keynote-045 – pembrolizumab as second-line treatment in urothelial carcinoma
-
2:00
exploring the combination of epacadostat and pembrolizumab in urothelial carcinoma
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc
-
1:05
dr. tara gangadhar on epacadostat/ pembrolizumab combination
-
1:00
pembrolizumab/axitinib and avelumab/axitinib combo for rcc
-
0:59
new data from the pacific trial for nsclc
-
6:32
keynote trials show pembrolizumab benefited patients with advanced small cell lung cancer
-
0:53
arc-8: ab680 zimberelimab for first-line mpdac
-
1:38
ecog1505: will avastin be treatment for early stage lung cancer patients?
-
4:45
biogenerator company accuronix is developing novel cancer therapy to kill cancer cells in new way
-
3:54
abiomed
-
0:37
pembrolizumab shows promise for advanced esophageal cancers
-
6:32
latest results from keynote-181: pembrolizumab versus chemotherapy as a second-line therapy for ...
-
2:56
keynote-010: pembrolizumab, anti-pd-1, for advanced nsclc with pd-l1 expression